With the announcements imminent on any or all of the decisions by the U.S. Supreme Court on the Affordable Care Act, University of Maryland, Baltimore offers to the media the following experts at this time from its professional schools of law, dentistry, nursing, and pharmacy. These experts are in addition to the law professors offered on these pages on June 11, 2012:
University of Maryland Francis King Carey School of Law:
Ellen Weber, JD, a professor and a member of the Law & Health Care Program. Weber founded the Drug Policy and Public Health Strategies Clinic at the School. She has studied Maryland’s implementation of the health benefit exchange, part of the federal health care law. Weber can address the Supreme Court ruling as it may impact people in Maryland with mental health and/or substance abuse issues, especially the low-income patients who stand to benefit from Medicaid.
University of Maryland School of Pharmacy:
Bruce Stuart, PhD, professor and executive director of the Peter Lamy Center on Drug Therapy and Aging is an economist and health services researcher. Today, with health care reform and expanding roles of pharmacists, the profession is currently on the cusp of new opportunities in integrated care partnerships involving providers, patients, employers, and insurers, he says. Stuart is an experienced research investigator having published over 150 papers with a current focus on Medicare Part D policy and its implications on drug utilization and outcomes for Medicare beneficiaries. In April 2012 he completed a 5-year term on the Medicare Payment Advisory Commission (MedPAC).
Magaly Rodriguez de Bittner, PharmD, BCPS, CDE, is a professor and chairperson of the University of Maryland School of Pharmacy's Department of Pharmacy Practice and Science. Rodriguez de Bittner practices in ambulatory care and community pharmacy practice sites, including the development, implementation and evaluation of innovative practice models in these settings. She is the Director of the Maryland P3 Program a medication therapy management program for patients with chronic diseases. She conducts research on the evaluation of the impact of these types of programs in the clinical, economic and humanistic outcomes of patients, expansion of community pharmacists’ clinical roles and overall improvement in health care delivery.
University of Maryland School of Dentistry:
Richard J. Manski, DDS, MBA, PhD, professor and director of health services research at the University of Maryland Dental School. He is a nationally recognized expertise in data analyses, oral health services research, and oral health policy. He is serving as a senior scholar at the Agency for Healthcare Research and Quality (AHRQ). Manski provides advice to AHRQ staff on issues related to measuring dental care expenditures, interpretation of dental health insurance benefits and methods for enhancement of subsequent waves within longitudinal Medical Expenditure Panel Survey studies. Manski has conducted analyses on and is fluent in the use of several nationally representative data sets including the Health and Retirement Study (HRS), the Medicare Current Beneficiary Survey (MCBS), the National Health Interview Survey (NHIS), the National Medical Care Expenditure Survey, the National Medical Expenditure Survey and the Medical Expenditure Panel Survey.
University of Maryland School of Nursing:
Kathryn Lothschuetz Montgomery, PhD, RN, NEA-BC, is an associate professor and associate dean for strategic partnerships & initiatives with the University of Maryland School of Nursing. Montgomery has been appointed to a four-year term on the Maryland Health Care Commission (MHCC) by Governor Martin O’Malley. The MHCC’s mission is to plan for health system needs, promote informed decision-making, increase accountability, and improve access in a rapidly changing health care environment by providing timely and accurate information on availability, cost, and quality of services to policy makers, purchasers, providers, and the public.